Literature DB >> 10840999

Long-term follow-up in diabetic Charcot feet with spontaneous onset.

J Fabrin1, K Larsen, P E Holstein.   

Abstract

OBJECTIVE: To assess the long-term results after Charcot breakdown with spontaneous onset in diabetic feet. RESEARCH DESIGN AND METHODS: This study was retrospective. A total of 115 patients (140 feet), 107 with acute deformity and 8 with chronic Charcot deformity, were followed for a median of 48 months (range 6-114). The routine treatment for acute cases was a weight-off regimen with crutches and foot protection with therapeutic shoes until skin temperature had normalized followed by increased weightbearing and the use of bespoke shoes or modification of conventional shoes.
RESULTS: The incidence of Charcot deformity was 0.3%/year in the diabetic population investigated. About half of the patients were active in their jobs. Major complications were encountered in 5 (4%) of the patients that required surgical intervention: arthrodesis for unstable malaligned ankles in 3 subjects (1 bilaterally) and major amputation in 2 subjects for unstable ankle and pressure sores. Minor complications were recorded in 43% of subjects: new attacks of Charcot breakdown in 41 patients (36%) and/or foot ulceration in 43 patients (37%) that required minor surgical procedures for 11 patients. All healed except in 2 patients: 1 patient died before the Charcot fractures had healed, and 1 patient died with an unhealed ulcer. No patient lost the ability to walk independently.
CONCLUSIONS: Major surgical procedures in only 4% were particularly related to patients with Charcot deformities in the ankle. Minor complications were recorded in about half of the patients. Lifelong foot care is required for diabetic patients with Charcot feet.

Entities:  

Mesh:

Year:  2000        PMID: 10840999     DOI: 10.2337/diacare.23.6.796

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  53 in total

Review 1.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

2.  The Charcot foot: medical and surgical therapy.

Authors:  Jan S Ulbrecht; Dane K Wukich
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

3.  Tarsal and metatarsal bone mineral density measurement using volumetric quantitative computed tomography.

Authors:  Paul K Commean; Tao Ju; Lu Liu; David R Sinacore; Mary K Hastings; Michael J Mueller
Journal:  J Digit Imaging       Date:  2008-05-14       Impact factor: 4.056

4.  Mortality associated with acute Charcot foot and neuropathic foot ulceration.

Authors:  Juliette van Baal; Richard Hubbard; Fran Game; William Jeffcoate
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

Review 5.  [Full contact plaster cast for conservative treatment of Charcot foot].

Authors:  K Trieb; F Ramadani; S G Hofstaetter
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

6.  [Pathophysiology and etiology of the Charcot foot].

Authors:  K Trieb; S G Hofstätter
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

Review 7.  Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.

Authors:  Brian M Schmidt; Crystal M Holmes
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

Review 8.  Update on Charcot neuroarthropathy.

Authors:  E B Jude; A J Boulton
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.

Authors:  Min-Woong Sohn; Rodney M Stuck; Michael Pinzur; Todd A Lee; Elly Budiman-Mak
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

10.  Role of quantitative bone scanning in the assessment of bone turnover in patients with Charcot foot.

Authors:  Robert Bem; Alexandra Jirkovská; Michal Dubsky; Vladimira Fejfarová; Marie Buncová; Jelena Skibová; Edward B Jude
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.